163 related articles for article (PubMed ID: 19487439)
1. Pharmacokinetic/pharmacodynamic analysis of the influence of inoculum size on the selection of resistance in Escherichia coli by a quinolone in a mouse thigh bacterial infection model.
Ferran AA; Kesteman AS; Toutain PL; Bousquet-Mélou A
Antimicrob Agents Chemother; 2009 Aug; 53(8):3384-90. PubMed ID: 19487439
[TBL] [Abstract][Full Text] [Related]
2. Influence of inoculum size and marbofloxacin plasma exposure on the amplification of resistant subpopulations of Klebsiella pneumoniae in a rat lung infection model.
Kesteman AS; Ferran AA; Perrin-Guyomard A; Laurentie M; Sanders P; Toutain PL; Bousquet-Mélou A
Antimicrob Agents Chemother; 2009 Nov; 53(11):4740-8. PubMed ID: 19738020
[TBL] [Abstract][Full Text] [Related]
3. Influence of inoculum size on the selection of resistant mutants of Escherichia coli in relation to mutant prevention concentrations of marbofloxacin.
Ferran A; Dupouy V; Toutain PL; Bousquet-Mélou A
Antimicrob Agents Chemother; 2007 Nov; 51(11):4163-6. PubMed ID: 17709467
[TBL] [Abstract][Full Text] [Related]
4. Mutant-prevention concentration and mechanism of resistance in clinical isolates and enrofloxacin/marbofloxacin-selected mutants of Escherichia coli of canine origin.
Gebru E; Choi MJ; Lee SJ; Damte D; Park SC
J Med Microbiol; 2011 Oct; 60(Pt 10):1512-1522. PubMed ID: 21596912
[TBL] [Abstract][Full Text] [Related]
5. In vivo pharmacodynamic efficacy of gatifloxacin against Streptococcus pneumoniae in an experimental model of pneumonia: impact of the low levels of fluoroquinolone resistance on the enrichment of resistant mutants.
Croisier D; Etienne M; Piroth L; Bergoin E; Lequeu C; Portier H; Chavanet P
J Antimicrob Chemother; 2004 Sep; 54(3):640-7. PubMed ID: 15317743
[TBL] [Abstract][Full Text] [Related]
6. In vitro pharmacodynamic evaluation of the mutant selection window hypothesis using four fluoroquinolones against Staphylococcus aureus.
Firsov AA; Vostrov SN; Lubenko IY; Drlica K; Portnoy YA; Zinner SH
Antimicrob Agents Chemother; 2003 May; 47(5):1604-13. PubMed ID: 12709329
[TBL] [Abstract][Full Text] [Related]
7. Integration of pharmacokinetic and pharmacodynamic indices of marbofloxacin in turkeys.
Haritova AM; Rusenova NV; Parvanov PR; Lashev LD; Fink-Gremmels J
Antimicrob Agents Chemother; 2006 Nov; 50(11):3779-85. PubMed ID: 16940071
[TBL] [Abstract][Full Text] [Related]
8. Determination of the in vivo pharmacodynamic profile of cefepime against extended-spectrum-beta-lactamase-producing Escherichia coli at various inocula.
Maglio D; Ong C; Banevicius MA; Geng Q; Nightingale CH; Nicolau DP
Antimicrob Agents Chemother; 2004 Jun; 48(6):1941-7. PubMed ID: 15155182
[TBL] [Abstract][Full Text] [Related]
9. Testing the mutant selection window hypothesis with Escherichia coli exposed to levofloxacin in a rabbit tissue cage infection model.
Ni W; Song X; Cui J
Eur J Clin Microbiol Infect Dis; 2014 Mar; 33(3):385-9. PubMed ID: 24036892
[TBL] [Abstract][Full Text] [Related]
10. The inoculum effect of Escherichia coli expressing mcr-1 or not on colistin activity in a murine model of peritonitis.
Fantin B; Poujade J; Grégoire N; Chau F; Roujansky A; Kieffer N; Berleur M; Couet W; Nordmann P
Clin Microbiol Infect; 2019 Dec; 25(12):1563.e5-1563.e8. PubMed ID: 31494253
[TBL] [Abstract][Full Text] [Related]
11.
Zhou YF; Tao MT; He YZ; Sun J; Liu YH; Liao XP
Antimicrob Agents Chemother; 2018 Jan; 62(1):. PubMed ID: 29038275
[TBL] [Abstract][Full Text] [Related]
12.
Zhao M; Lepak AJ; Marchillo K; VanHecker J; Andes DR
Antimicrob Agents Chemother; 2018 Sep; 62(9):. PubMed ID: 29987156
[TBL] [Abstract][Full Text] [Related]
13.
Zhao M; Lepak AJ; Marchillo K; VanHecker J; Andes DR
Antimicrob Agents Chemother; 2017 Jul; 61(7):. PubMed ID: 28416552
[TBL] [Abstract][Full Text] [Related]
14. Pharmacodynamics of a novel des-F(6)-quinolone, BMS-284756, against Streptococcus pneumoniae in the thigh infection model.
Nicolau DP; Mattoes HM; Banevicius M; Xuan D; Nightingale CH
Antimicrob Agents Chemother; 2003 May; 47(5):1630-5. PubMed ID: 12709332
[TBL] [Abstract][Full Text] [Related]
15. Emergence of resistant Streptococcus pneumoniae in an in vitro dynamic model that simulates moxifloxacin concentrations inside and outside the mutant selection window: related changes in susceptibility, resistance frequency and bacterial killing.
Zinner SH; Lubenko IY; Gilbert D; Simmons K; Zhao X; Drlica K; Firsov AA
J Antimicrob Chemother; 2003 Oct; 52(4):616-22. PubMed ID: 12951352
[TBL] [Abstract][Full Text] [Related]
16. In vivo evaluation of mutant selection window of cefquinome against Escherichia coli in piglet tissue-cage model.
Zhang B; Gu X; Li Y; Li X; Gu M; Zhang N; Shen X; Ding H
BMC Vet Res; 2014 Dec; 10():297. PubMed ID: 25511985
[TBL] [Abstract][Full Text] [Related]
17. In vivo activity of cefquinome against Escherichia coli in the thighs of neutropenic mice.
Shan Q; Liang C; Wang J; Li J; Zeng Z
Antimicrob Agents Chemother; 2014 Oct; 58(10):5943-6. PubMed ID: 25070101
[TBL] [Abstract][Full Text] [Related]
18. Mutant prevention concentrations of pradofloxacin for susceptible and mutant strains of Escherichia coli with reduced fluoroquinolone susceptibility.
Marcusson LL; Komp Lindgren P; Olofsson SK; Hughes D; Cars O
Int J Antimicrob Agents; 2014 Oct; 44(4):354-7. PubMed ID: 25129317
[TBL] [Abstract][Full Text] [Related]
19. Selection of ciprofloxacin resistance in Escherichia coli in an in vitro kinetic model: relation between drug exposure and mutant prevention concentration.
Olofsson SK; Marcusson LL; Komp Lindgren P; Hughes D; Cars O
J Antimicrob Chemother; 2006 Jun; 57(6):1116-21. PubMed ID: 16624874
[TBL] [Abstract][Full Text] [Related]
20. Enrichment of fluoroquinolone-resistant Staphylococcus aureus: oscillating ciprofloxacin concentrations simulated at the upper and lower portions of the mutant selection window.
Firsov AA; Lubenko IY; Smirnova MV; Strukova EN; Zinner SH
Antimicrob Agents Chemother; 2008 Jun; 52(6):1924-8. PubMed ID: 18378704
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
